Article

Evaluate all patients for dry eye before refractive surgery

Dry eye symptoms and fluctuating or decreased visual acuity due to ocular surface disease puts individuals at increased risk for refractive surgery-related dry eye.

Key Points

"Dry eye is potentially one of the most devastating non-flap-related complications associated with refractive surgery," explained Dr. Donnenfeld. "However, the risk of this complication can be minimized with an intelligent surgical, pharmacologic, and behavioral approach to refractive surgery." He spoke during the Refractive Surgery Subspecialty Day meeting, sponsored by the International Society of Refractive Surgery of the American Academy of Ophthalmology.

"I consider these stains vital to dry eye evaluation, and I look at them like a traffic light," Dr. Donnenfeld said. "All these stains tell me to slow down or stop because the patient may not be a candidate for refractive surgery."

Who should avoid surgery?

"If a patient has dry eye symptoms but they have no effect on vision, the patient is usually a good candidate [for refractive surgery]," he said. "If a patient has dry eye symptoms and fluctuating vision, the individual is a moderate or poor candidate. For those patients with dry eye symptoms and decreased visual acuity due to ocular surface disease, they are not candidates for refractive surgery."

Dry eye signs

Patients are good candidates for refractive surgery if they have no dry eye symp toms exhibited by supravital staining of the conjunctiva. Individuals are considered moderate candidates if they have supravital staining of the conjunctiva but no corneal staining. If patients have both supravital staining of the conjunctiva and central fluorescein corneal staining, they should not undergo refractive surgery, Dr. Donnenfeld warned.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.